Search results
AB InBev (BUD) Stays on Growth Track on Ongoing Initiatives
Zacks via Yahoo Finance· 20 hours agoThe consensus estimate for Vital Farms’ current financial year’s sales and earnings per share...
In-N-Out confirms price changes on Double-Double and other menu items
ABC News· 20 hours agoWhile the Irvine-based fast food chain has previously maintained famously low prices for its hot,...
The best Pride Month 2024 deals to shop now
Reviewed via Yahoo News· 21 hours agoHow to celebrate Pride Month 2024 Pride Month is typically marked by festivals, parades...Pride Month 2024 is the perfect opportunity to support the...
Price hikes and boycotts: Is trouble brewing at Starbucks?
BBC via Yahoo News· 5 days agoLike Starbucks, a slew of other big fast-food brands, including McDonald's, Wendy's and Burger...
How could global turmoil affect the election in Scotland?
BBC via Yahoo News· 2 days agoAs Western nations imposed sanctions on Russia, oil and gas prices soared, and supplies of wheat,...
Launch of the WHO guideline on fiscal policies to promote healthy diets
World Health Organization· 4 hours agoThe Department of Nutrition and Food Safety (NFS) is launching its new guideline on fiscal policies to promote healthy diets. The guideline provides countries with recommendations ...
Starbucks Stock Will Get a Jolt. Coffee Shops Are Strong.
Barrons.com· 6 hours agoShares are now trading at 20 times next fiscal year earnings, much lower than the five-year average...
Home Decor Prices Are Supposed to Be on the Decline—Interior Designers Say They Haven’t Felt It...
Market Watch· 19 hours ago“I’m not sure that we’ve seen much decreasing at all,” said Gary Eisner, founding partner of...
Three Chinese Dividend Stocks Offering Up To 3.5% Yield
Simply Wall St. via Yahoo Finance· 13 hours agoAs global markets navigate through mixed economic signals, with some regions showing signs of...
Eli Lilly stock hits all-time high: What’s been driving the pharma giant’s share price higher?
Bankrate via Yahoo Finance· 2 days agoAcquisitions, such as that of cancer drug maker POINT Biopharma Global in December 2023, are seen as...